← Comparing 2 hypotheses side-by-side
Add hypothesis:
— Select a hypothesis to add —
TBK1 Loss Triggers eIF2α-Mediated Translational Repression T (TBK1, EIF2S1) — 0.00 eIF2α Phosphorylation Imbalance Disrupts Mitochondrial Prote (EIF2S1,eIF2α,PERK,GCN2,ATF4,TOMM20,TIMM23,NDUFS1,NDUFS3,COX4I1,COX5A,mitochondrial protein import) — 0.00 TBK1 Loss Triggers Astrocyte-to-Neuron Senescence Propagatio (TBK1 → NF-κB / IRF3 / p62-autophagy / SASP effectors) — 0.00 GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Cl (GRIN2B) — 0.96 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.96 Closed-loop optogenetic targeting PV interneurons to restore (PVALB) — 0.95 Plasma NfL Elevation Secondary to BBB-Associated Transport D (NEFL) — 0.94 Closed-loop transcranial focused ultrasound to restore hippo (CCK) — 0.91 Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming (NLRP3, CASP1, IL1B, PYCARD) — 0.91 Gamma entrainment therapy to restore hippocampal-cortical sy (SST) — 0.90 Hypothesis 4: Metabolic Coupling via Lactate-Shuttling Colla (SLC16A1, SLC16A7, LDHA, PDHA1) — 0.89 SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senesc (SIRT1) — 0.89 TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegener (TREM2) — 0.89 Multi-Target Hypothesis: Aβ-Induced Cholinergic Damage is Pa (APP/PSEN1 (Aβ production), CHAT (cholinergic synthesis)) — 0.89 Optimized Temporal Window for Metabolic Boosting Therapy Det (IFNG) — 0.89 TREM2-APOE Axis Dissociation for Selective DAM Activation (TREM2-APOE axis) — 0.89 p38α Inhibitor and PRMT1 Activator Combination to Restore Ph (MAPK14/PRMT1) — 0.88 APOE-Dependent Autophagy Restoration (MTOR) — 0.88 Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95 (BDNF) — 0.87 ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro (ACSL4) — 0.87 Complement Cascade Inhibition Synaptic Protection (%s) — 0.87 eIF2α Phosphorylation Imbalance Creates Integrated Stress Re (EIF2S1,eIF2α,PERK,GCN2,ATF4,ATF5,CHOP,DDIT3,integrated stress response,protein synthesis) — 0.87 Optogenetic restoration of hippocampal gamma oscillations vi (PVALB) — 0.87 Gamma Oscillation Entrainment Enhances lncRNA-9969-Mediated (PVALB, CREB1, lncRNA-9969, neuronal autophagy pathway) — 0.87 Glymphatic-Mediated Tau Clearance Dysfunction (MAPT) — 0.86 Closed-loop focused ultrasound targeting EC-II PV interneuro (PVALB) — 0.86 TREM2 R47H Variant-Driven Metabolic Dysfunction as the Prima (NAMPT) — 0.86 TREM2-Mediated Microglial Dysfunction Disrupts Perivascular (TREM2) — 0.86 Circadian Glymphatic Entrainment via Targeted Orexin Recepto (HCRTR1/HCRTR2) — 0.86 RBM45 Liquid-Liquid Phase Separation Dominance Hijacks RNA P (RBM45,GSK3B,TDP-43,TARDBP,hnRNP A1,HNRNPA1,phase separation,Liquid droplet) — 0.86
Add
|
× Glucosylceramide Accumula × GBA1-Deficiency Disrupts
GBA1 · neurodegeneration · mechanistic
Composite 0.700
Price $0.50
Evidence For 0
Evidence Against 0
GCase deficiency in PD-linked GBA1 mutations leads to progressive glucosylceramide (GlcCer) accumulation in lysosomal membranes, fundamentally altering their biophysical properties. GlcCer preferentially localizes to ordered lipid domains (lipid rafts), which are precisely the membrane microdomains required for SNX5 (sorting nexin 5) association with the retromer complex. SNX5 serves as a critical bridge between the VPS35-VPS29-VPS26 trimer and phosphoinositide-specific membranes, mediating the
GBA1 · neurodegeneration · mechanistic
Composite 0.747
Price $0.50
Evidence For 0
Evidence Against 0
GBA1 deficiency leads to glucosylceramide accumulation in the inner mitochondrial membrane (as shown by lipidomics of patient fibroblasts), which directly stabilizes Miro1 protein levels by inhibiting the mitochondrial protease LONP1. Miro1 is a calcium-sensitive adaptor that tethers mitochondria to the microtubule motor complex; under normal conditions, Miro1 is ubiquitinated by the Pink1-Parkin pathway and degraded to enable mitophagosome formation. When GlcCer stabilizes Miro1, damaged mitoch
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
GBA1 Inter Organelle Crosstalk Lipid Metabolism neurodegeneration
Convergent signals
GBA1 recurs across 2 selected hypotheses with aligned directionality in inter organelle crosstalk, lipid metabolism.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary 6/11
dimensions won
Glucosylceramide Accumulation from GCase
2/11
dimensions won
GBA1-Deficiency Disrupts Mitochondrial-
Radar Chart — 10 Dimensions
Score Breakdown
Dimension Glucosylceramide Accumulation GBA1-Deficiency Disrupts Mitoc Mechanistic 0.780 0.740 Evidence 0.780 0.680 Novelty 0.720 0.820 Feasibility 0.750 0.000 Impact 0.760 0.000 Druggability 0.000 0.000 Safety 0.000 0.000 Competition 0.000 0.000 Data 0.000 0.000 Reproducible 0.550 0.000 KG Connect 0.500 0.500
Evidence Glucosylceramide Accumulation from GCase Deficiency Disrupts No evidence citations yet
GBA1-Deficiency Disrupts Mitochondrial- Lysosomal Contact Si No evidence citations yet
Price History Overlay